Search results
Results From The WOW.Com Content Network
SynCardia Systems, LLC, headquartered in Tucson, Arizona, was founded in 2001 and is the sole manufacturer and provider of the world's only clinically proven and commercially approved Total Artificial Heart. [1] The SynCardia temporary Total Artificial Heart (TAH) has been in clinical use for more than 35 years. [2]
An artificial heart is an artificial organ device that replaces the heart.Artificial hearts are typically used to bridge the time to complete heart transplantation surgery, but research is ongoing to develop a device that could permanently replace the heart in the case that a heart transplant (from a deceased human or, experimentally, from a deceased genetically engineered pig) is unavailable ...
Jack Greene Copeland (born 1942) is an American cardiothoracic surgeon, who has established procedures in heart transplantation including repeat heart transplantation, the implantation of total artificial hearts (TAH) to bridge the time to heart transplant, innovations in left ventricular assist devices (LVAD) and the technique of "piggybacking" a second heart (heterotopic heart transplant) in ...
AbioCor was a total artificial heart (TAH) developed by the Massachusetts-based company AbioMed.It was fully implantable within a patient, due to a combination of advances in miniaturization, biosensors, plastics and energy transfer.
Rodger Ford is the managing partner at Anthem Equity Group. [1] He has also managed two medical device companies. Ford founded AlphaGraphics, a printshop business, in 1970.. In 1979, the company began franchising its operations [2] and, during the 1980s, helped the company grow their franchise business
William DeVries was born December 19, 1943, in Brooklyn Navy Yard.His father, Henry DeVries, was a Dutch immigrant who died in combat on the destroyer USS Kalk (DD-611) in 1944 during the Battle of Hollandia, [1] where he had enrolled as a naval surgeon.
Wayne Robert Griffin (born 1975) is the second person in Australia to be implanted with the SynCardia Total artificial heart. [1] The artificial heart surgery was performed on 20 August 2010, by Dr. Phillip Spratt, the head of the Heart and Lung Transplant Unit of St Vincent's Hospital. He was assisted by Dr. Paul Jantz and supervised by Dr ...
H. Hajdu–Cheney syndrome; Hancock Aortic Tissue Valve; HDL-Atherosclerosis Treatment Study; Heart Failure Society of America; Heart Protection Study; Heart rate recovery